US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

665.74

-8.4209-1.25%

Number of Gainers:70

Number of Losers:70

Number of Flat:13

PE:- -

High:687.10

Open:668.22

Low:665.46

Close:674.17

Volume:284.69M

Turnover:11.42B

Market Cap:459.41B

Float Cap:358.92B

Loading ...

Coinbase: Some Users May Experience Delays in Sends and Receives of Avalanche (Avax) Due to a Scheduled Network Upgrade

THOMSON REUTERS

RxSight is Maintained at Hold by Jefferies

Qyuns Therapeutics Updates Board Composition and Governance Structure

Qyuns Therapeutics Raises QX001S Deal Caps and Refreshes Board Line-Up

IPOWER Stockholders Approve Capital and Incentive Changes

Global-E Online President Debbi Nir Disposes of 8,332 Common Shares Worth $307,385.61

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Nexxen U Launches ‘Data for the Converged Media World,’ Building on Program Momentum and Industry Demand

Forvis Mazars Capital Advisors Selects Intapp DealCloud with Celeste for Deal Workflow Automation

Forvis Mazars Capital Advisors Selects Intapp Dealcloud with Celeste to Advance Firmwide Agentic AI Strategy

THOMSON REUTERS

iPower Shareholders Approve $10 Million Common Stock Issuance at Special Meeting

BofA Adjusts Price Target on RxSight to $5.50 From $6.50

MT Newswires Live

Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium

Marker Therapeutics highlights expanded manufacturing support of CDMO partner

Transcode Therapeutics - Announces Patent Advancements in Australia and Japan for Rna Platform

THOMSON REUTERS

Zeta Global Names Lalitha Stables President, UK

TransCode Therapeutics Says Australia Accepts Patent Application for siRNA Cancer Nanoparticle Delivery

Zeta Global Invests in U.k. Growth with New London Hub and Leadership

THOMSON REUTERS

Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies

US Stocks on the MOVE-Vicor, Valero Energy, Crane NXT

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK4539/news?page=33"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":665.74475,"timestamp":1790971199999,"preClose":674.16565,"halted":0,"volume":284690200,"delay":0,"changeRate":-0.012491,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-8.420898,"latestTime":"10-02 16:00:00 EDT","open":668.2159,"high":687.09705,"low":665.4622,"amount":11415788801.016344,"amplitude":0.032091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.201059,"peRate":114.807925,"turnoverRate":0.022399,"increases":70,"decrements":70,"flats":10,"marketCap":459409451462.5,"floatMarketCap":358922617098.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":687.09705,"amplitude":0.032091,"preClose":674.16565,"low":665.4622,"pbRate":"5.201059","latestPrice":665.74475,"volume":284690200,"delay":0,"open":668.2159,"prevYearClose":881.5255,"prevWeekClose":697.624,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":697.624,"twentyDayClose":733.4782,"sixtyDayClose":783.9062,"secType":"PLATE","market":"US","turnoverRate":0.022399,"peRate":114.807925,"marketCap":459409451462.5,"floatMarketCap":358922617098.875,"timestamp":1790971199999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":70,"down":70,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:33,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669123216","title":"Coinbase: Some Users May Experience Delays in Sends and Receives of Avalanche (Avax) Due to a Scheduled Network Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669123216?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:37","pubTimestamp":1790091477,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0G2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4600","BK4588","BK4516","BK4595","07311","LU2360107671.USD","BK4554","09711","LU1861217088.USD","DAPP","07711","FINX","09311","LU1861558580.USD","COIN","BK4585","IBLC","LU1861220207.SGD","BK4596","COIX","FIAT","COIG","LU1861559042.SGD","COIW","BLCK","CONX","COIA","BK4112","AVAX.USD.CC","CONI","CONL","FDIG","ICOI","BKCH","BK4539","COIO","BK4535","COII","CRPT","COYY","CONY","BITQ","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669397128","title":"RxSight is Maintained at Hold by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2669397128","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669397128?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:23","pubTimestamp":1790086980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RXST/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BK4539","RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669140799","title":"Qyuns Therapeutics Updates Board Composition and Governance Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669140799","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669140799?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:08","pubTimestamp":1790086101,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. Class H ( ($HK:2509) ) has shared an update. Qyuns Therapeutics Co., Ltd. is a joint stock biopharmaceutical company i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-updates-board-composition-and-governance-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-updates-board-composition-and-governance-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147753","title":"Qyuns Therapeutics Raises QX001S Deal Caps and Refreshes Board Line-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147753","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147753?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:37","pubTimestamp":1790084237,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. Class H ( ($HK:2509) ) has issued an announcement. Qyuns Therapeutics plans to revise the annual caps for its QX001S f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-raises-qx001s-deal-caps-and-refreshes-board-line-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-raises-qx001s-deal-caps-and-refreshes-board-line-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147751","title":"IPOWER Stockholders Approve Capital and Incentive Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147751","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147751?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:33","pubTimestamp":1790084010,"startTime":"0","endTime":"0","summary":"IPOWER ( ($IPW) ) has shared an announcement. On September 21, 2026, IPOWER held a special meeting of stockholders at which shareholders voted on t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ipower-stockholders-approve-capital-and-incentive-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ipower-stockholders-approve-capital-and-incentive-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BK4122","BK4539","IPW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147818","title":"Global-E Online President Debbi Nir Disposes of 8,332 Common Shares Worth $307,385.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147818","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147818?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:15","pubTimestamp":1790082923,"startTime":"0","endTime":"0","summary":"Global-e Online President Debbi Nir disposes of 8,332 common shares worth $307,385.61Global-e Online President Debbi Nir sold 8,332 ordinary shares on Sep. 16, 2026 at a weighted average USD 36.89.Dir","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL4gW7vz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Global-E Online President Debbi Nir Disposes of 8,332 Common Shares Worth $307,385.61","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GLBE","BK4122","BK4220","BK4539","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174429461","title":"Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1174429461","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174429461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082018,"startTime":"0","endTime":"0","summary":"Viking Therapeutics (VKTX.US) saw its shares spike nearly 50% in Tuesday's premarket trading after the biotech announced that its experimental obesity drug, VK2735, helped patients maintain most of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","THNR","BK4007","NBDS","PINK","BK4139","BK4599","TRUH","BK4585","IYH","RSPH","FXH","OZEM","FHLC","NVOH","PJP","VKTX","LENZ","MEDI","BK4539","CURE","XLVI","NVOX","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669295142","title":"Nexxen U Launches ‘Data for the Converged Media World,’ Building on Program Momentum and Industry Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2669295142","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669295142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":"Award-winning educational series helps media teams turn convergence into performance, leveraging expertise from Tastemade, Omnicom Media and A+ENEW YORK, Sept.  22, 2026 (GLOBE NEWSWIRE) -- Nexxen, th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366380/0/en/nexxen-u-launches-data-for-the-converged-media-world-building-on-program-momentum-and-industry-demand.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4009","NEXN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669014400","title":"Forvis Mazars Capital Advisors Selects Intapp DealCloud with Celeste for Deal Workflow Automation","url":"https://stock-news.laohu8.com/highlight/detail?id=2669014400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669014400?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:45","pubTimestamp":1790081116,"startTime":"0","endTime":"0","summary":"Forvis Mazars Capital Advisors selects Intapp DealCloud with Celeste for deal workflow automationIntapp reported Forvis Mazars Capital Advisors selected DealCloud with Celeste as part of a firmwide ag","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDLbqhxc8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","INTA","BK4023","LU0757428866.USD","LU1815336091.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669614400","title":"Forvis Mazars Capital Advisors Selects Intapp Dealcloud with Celeste to Advance Firmwide Agentic AI Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2669614400","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669614400?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:45","pubTimestamp":1790081100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA9WBNY2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4023","BK4539","LU0757428866.USD","LU1815336091.USD","INTA","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144752","title":"iPower Shareholders Approve $10 Million Common Stock Issuance at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144752","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144752?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:40","pubTimestamp":1790080852,"startTime":"0","endTime":"0","summary":"iPower shareholders approve $10 million common stock issuance at special meetingiPower held a special shareholder meeting on Sept. 21, 2026.Shareholders authorized issuance of up to $10 million of com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL1SWZ5k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPW","BK4539","BK4104","BK4122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461144","title":"BofA Adjusts Price Target on RxSight to $5.50 From $6.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461144","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669461144?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:32","pubTimestamp":1790080354,"startTime":"0","endTime":"0","summary":"RxSight (RXST) has an average rating of hold and mean price target of $7.57, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4198","RXST","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669440191","title":"Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2669440191","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669440191?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:30","pubTimestamp":1790080200,"startTime":"0","endTime":"0","summary":"DOYLESTOWN, Pa., Sept.  22, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366342/0/en/aprea-therapeutics-to-present-updated-interim-phase-1-data-on-wee1-inhibitor-apr-1051-in-an-oral-presentation-at-38th-eortc-nci-aacr-symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK1184","LU0572940350.SGD","LU0572939691.SGD","LU0264606111.USD","LENZ","01336","BK1584","BK4007","BK1550","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144227","title":"Marker Therapeutics highlights expanded manufacturing support of CDMO partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144227","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144227?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:20","pubTimestamp":1790079621,"startTime":"0","endTime":"0","summary":"Marker Therapeutics (MRKR) highlighted the expanded infrastructure, technical expertise and manufacturing capabilities supporting its lead program,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/marker-therapeutics-highlights-expanded-manufacturing-support-of-cdmo-partner-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/marker-therapeutics-highlights-expanded-manufacturing-support-of-cdmo-partner-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","CDMO","MRKR","BK4007","LENZ","EES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669410941","title":"Transcode Therapeutics - Announces Patent Advancements in Australia and Japan for Rna Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2669410941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669410941?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:12","pubTimestamp":1790079148,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141249","title":"Zeta Global Names Lalitha Stables President, UK","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141249","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141249?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:06","pubTimestamp":1790078800,"startTime":"0","endTime":"0","summary":"Zeta Global names Lalitha Stables president, UKZeta Global appointed Lalitha Stables as president of its U.K. business.Stables previously served as general manager and country manager, U.K., at HubSpo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL7X8bbn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","ZETX","ZETA","BK4539","IE00BFMHRM44.USD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412441","title":"TransCode Therapeutics Says Australia Accepts Patent Application for siRNA Cancer Nanoparticle Delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412441","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412441?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:06","pubTimestamp":1790078772,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics says Australia accepts patent application for siRNA cancer nanoparticle deliveryTransCode Therapeutics reported patent progress in Australia, citing acceptance of an application","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL26Yw6T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141407","title":"Zeta Global Invests in U.k. Growth with New London Hub and Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141407?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:05","pubTimestamp":1790078700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABKCBGH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFMHRM44.USD","BK4613","ZETX","BK4539","BK4023","ZETA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142898","title":"Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142898","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142898?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"HOUSTON, Sept.  22, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company developing multi-antigen recognizing (MAR)-T cell therapies for the trea","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366273/0/en/marker-therapeutics-highlights-expanded-manufacturing-support-of-cdmo-partner-following-formation-of-kincellis-advanced-therapies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BD0PCF45.HKD","LENZ","BK4007","GB00B4LPDJ14.GBP","BK4157","IE00B66KJ199.SGD","LU1718418525.SGD","BK4139","LU0274383776.USD","GB00B4QBRK32.GBP","CAR","MAR","IE0031619046.USD","LU2404859667.USD","IE00B0T0GQ85.USD","LU2089985449.USD","IE00B19Z4B17.USD","BK4142","LU2404859741.USD","BK4022","LU0757428866.USD","IE00B1G9WX41.USD","LU1815336091.USD","BK4230","AEIS","CDMO","BK4585","LU0690374961.EUR","IE00B95QR487.USD","LU2931357623.SGD","EES","BK4588","LU0690374615.EUR","BK4539","IE00B7SZL793.SGD","IE00B45NX917.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141302","title":"US Stocks on the MOVE-Vicor, Valero Energy, Crane NXT","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141302","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141302?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:54","pubTimestamp":1790078081,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Vicor, Valero Energy, Crane NXTSeptember 22 (Reuters)-Wall Street's main indexes were steady on Tuesday, following AI-driven gains in the previous session, while investors a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL6N45E0IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0630314457.HKD","RSPG","MAAY","COIX","MARA","BKCH","BK4600","HUTG","LU0096364046.USD","COIW","CONX","FINX","BLCK","SG9999001440.SGD","CXT","BLOX","TNGY","LU0069063385.USD","09711","MARO","LU0456854461.SGD","IE00BGHQF524.EUR","WEEI","LU0757428866.USD","MHX","PXE","CONL","CRPT","LU0345781412.USD","BK4596","09311","OWNB","BK4554","LU0266512127.USD","IBLC","COYY","COIN","IEO","IE00BSNM7G36.USD","RIOX","LU0300736492.USD","LU0368265418.SGD","VLO","LU0289739343.SGD","BK4595","BK4547","COIA","LU2089985449.USD","ICOI","LU0122376428.USD","IE00B3CCJ963.GBP","LU0061475181.USD","RTYY","LU1815336091.USD","BK4588","DRLL","LU0289961442.SGD","BK4096","BK4146","MRAL","BK4023","FENY","LU2265009873.SGD","ONON","IMRA","LU1861220207.SGD","LU0274383776.USD","MNRS","TRUN","LU0788109394.HKD","HUT","PXI","BK4539","COIG","XLE","BK4157","DAPP","LU1861217088.USD","LU1868837136.USD","LU1861559042.SGD","BK4516","BITQ","CONY","LU1804176565.USD","LU0053671581.USD","LU2931357623.SGD","LU1861558580.USD","RIOT","IE00B2Q91V27.USD","LU0511384066.AUD","CONI","LU0472753341.HKD","BK4138","BK4585","BK4161","COII","VICR","CRAK","FDIG","LU1868836757.USD","LU1868837300.USD","LU0345780950.USD","07711","LU0057025933.USD","BK4535","BK4551","GXPE","BK4112","LU0266512473.USD","WGMI","IYE","LU1868836591.USD","LFGY","LU2360107671.USD","LU1868836914.USD","FIAT","COIO","07311"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":39,"pageCount":33,"totalSize":774,"code":"91000000","status":"200"}]}}